Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8244922 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusion: For patients with head-and-neck cancer receiving CRT, intravenous l-alanyl-l-glutamine may be an effective preventive measure to decrease the severity of mucositis.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Leandro C.A. M.D., Alfredo H. M.D., Ph.D., Maribel A. M.D., Monica A. M.D., Ricardo M.D., Marcelo M.D., Maria Esther M.D., Berta M.D., Graciela Pharm.D., Beatriz Pharm.D., Patricia Pharm.D.,